Chiral bioequivalence: Effect of absorption rate on racemic etodolac

Clinical Pharmacokinetics

Volumn 39, Issue 6, 2000, Pages 459-469

  Boni, J P ^a   Korthbradley, J M ^a   Richards, L S ^a   Chiang, S T ^a   Hicks, D R ^b   Benet, L Z ^c  

^a WYETH AYERST RESEARCH   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETODOLAC;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CHIRALITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG STRUCTURE; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; ISOMERISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034495319     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-200039060-00006     Document Type: Article

References (41)

1. Enantioselectivity pharmacodynamics and pharmacokinetics of chiral non-steroidal antiinflammatory drugs
2. Stereochemistry as a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology
3. Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans
4. Effect of route of administration on the chiral inversion of R-(-)-ibuprofen
5. The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans
6. Stereospecific disposition of flunoxaprofen enantiomers in human beings
7. Pharmacokinetics of the enantiomers of indoprofen in man
8. 14C]-etodolac in man
9. Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs
10. Etodolac clinical pharmacokinetics
11. The pharmacokinetics of etodolac enantiomers in the rat: Lack of pharmacokinetic interaction between enantiomers
12. Plasma propranolol levels in quantitative assessment of beta-adrenergic blockade in man
13. Comparative human study of ibuprofen enantiomer plasma concentrations produced by two commercially available ibuprofen tablets
14. Alterations in apparent bioequivalency of ibuprofen based on isomer analysis
15. Stereoselective first-pass metabolism of highly cleared drugs: Studies of the bioavailability of L- and D-verapamil examined with stable isotope technique
16. Predictability of the in vivo metabolism of verapamil from in vitro data: Contribution of individual metabolic pathways and stereoselective aspects
17. Which bioequivalence study for a racemic drug? Application to milnacipran
18. Bioequivalence of racemic drugs
19. Enantioselective assays in comparative bioavailability studies of racemic drug formulations: Nice to know or need to know?
20. Guidelines for collection and analysis of pharmacokinetic data
21. A comparison of the two-one sided tests procedure and the power approach for assessing the equivalence of average bioavailability
22. Introduction
23. Bioequivalence of chiral drugs
24. Stereoselective disposition and pharmacologic activity of propafenone enantiomers
25. The effects of the stereoisomers of propafenone and diprafenone in guinea-pig heart
26. Different stereoselective effects of (R)- and (S)-propafenone: Clinical, pharmacologic, electrophysiologic, and radioligand binding studies
27. Stereoselective electrophysiological effects of propafenone in Langendorff perfused guinea pig hearts
28. Stereospecific assay of nicoumalone: Application to pharmacokinetic studies in man
29. Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin
30. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans
31. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy
32. Stereoselective disposition and glucuronidation of propranolol in humans
33. Simultaneous first-order and capacity-limited elimination kinetics after oral administration of verapamil
34. Stereoselective, competitive, and nonlinear plasma protein binding of ibuprophen enantiomers as determined in vivo in healthy subjects
35. Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans
36. Pharmacokinefic and pharmacodynamic action of etodolac in patients after oral surgery